AEENA Dx
Signal active
Organization
Contact Information
Overview
AEENA Dx is developing a saliva-based platform for the detection of cancer and disease.
About
Industries
Biotechnology, Health Care, Genetics
Founded
2011
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
AEENA Dx headquartered in United States, North America, operates in the Biotechnology, Health Care, Genetics sector. The company focuses on Biotechnology and has secured $439.0M in funding across 108 round(s). With a team of 1-10 employees, AEENA Dx is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - AEENA Dx, raised $192.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
0
Lead Investors
0
Total Funding Amount
$4.1M
Details
8
AEENA Dx has raised a total of $4.1M in funding over 8 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | |||
| 2022 | Early Stage Venture | |||
| 2013 | Seed | |||
| 2011 | Seed | 192.0K |
Investors
AEENA Dx is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Claire England | - | FUNDING ROUND - Claire England | undefined |
| Trish Costello | - | FUNDING ROUND - Trish Costello | undefined |
| AEENA Dx | - | FUNDING ROUND - AEENA Dx | undefined |
| Portfolia | - | FUNDING ROUND - Portfolia | undefined |
Recent Activity
There is no recent news or activity for this profile.